Mfgr's of Aug 12th, 2024: Phase II study that w
Post# of 146071
![](/assets/46931549/no_avatar_available_thumb.jpg)
Phase II study that will investigate the preliminary safety and activity of leronlimab in combination with trifluridine plus tipiracil (TAS-102) and bevacizumab
_____
* Sandoz and Monarch Pharma are generic manufacturers of trifluridine
*Trifluridine is also an ingredient in the oral anti-cancer drug trifluridine/tipiracil, which is sold under the brand name Lonsurf.
_____
Bevacizumab
*Amneal Pharmaceuticals, Inc. is a manufacturer of a biosimilar version of bevacizumab, called ALYMSYS (bevacizumab-maly).
______
Largest generic manufacturer:
Teva Pharmaceutical
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)